Who
Todd Newton
Director
Company insider
Files Form 4 as: Interim CEO, MiMedx Group; Chief Executive Officer, Apollo Endosurgery; EVP, CFO & COO, Arthrocare.
In numbers
- Trades disclosed
- 66
- Buys
- 8
- Sells
- 0
- Bought
- $1.5M
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 16 Dec 2009
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $185K50,913 at $3.64 | filing |
| 10 Jun 2026filed 12 Jun 2026 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $185K50,913 at $3.64 | filing |
| —filed 23 Jun 2025 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $185K28,609 at $6.47 | filing |
| 5 Jun 2024filed 6 Jun 2024 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $168K23,190 at $7.26 | filing |
| 13 Jun 2023filed 15 Jun 2023 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $175K35,354 at $4.95 | filing |
| 15 Sep 2022filed 19 Sep 2022 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 7 Jun 2022filed 13 Jun 2022 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $175K44,191 at $3.96 | filing |
| 27 May 2021filed 28 May 2021 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $175K17,056 at $10.26 | filing |
| 5 Jan 2021filed 7 Jan 2021 | Apollo Endosurgery | SEC FORM 4 Code J | —3,479 at $0.00 | filing |
| 2 Oct 2020filed 5 Oct 2020 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $175K26,236 at $6.67 | filing |
| 5 Aug 2020filed 6 Aug 2020 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | —38,135 at $0.00 | filing |
| 7 May 2020filed 11 May 2020 | Apollo Endosurgeryoption or derivative | SEC FORM 4 Code A | $239K115,094 at $2.08 | filing |
| 7 May 2020filed 11 May 2020 | Apollo Endosurgery | SEC FORM 4 Code A | —77,075 at $0.00 | filing |
| 3 Jan 2020filed 6 Jan 2020 | Apollo Endosurgery | SEC FORM 4 Code J | —3,296 at $0.00 | filing |
| 12 Aug 2019filed 14 Aug 2019 | Apollo Endosurgeryoption or derivative | SEC FORM 4 Code P | — | filing |
| 14 May 2019filed 14 May 2019 | Apollo Endosurgery | SEC FORM 4 Code A | $13K3,600 at $3.54 | filing |
| 10 May 2019filed 14 May 2019 | Apollo Endosurgery | SEC FORM 4 Bought | $88K25,000 at $3.53 | filing |
| 7 May 2019filed 10 May 2019 | Apollo Endosurgeryoption or derivative | SEC FORM 4 Code A | $170K48,673 at $3.49 | filing |
| 7 May 2019filed 10 May 2019 | Apollo Endosurgery | SEC FORM 4 Code A | —31,250 at $0.00 | filing |
| 20 Jun 2018filed 22 Jun 2018 | Apollo Endosurgery | SEC FORM 4 Bought | $400K72,727 at $5.50 | filing |
News
No headline names them, or the companies they trade most, lately.